Literature DB >> 3463998

Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.

R Mira-y-Lopez, J Joseph-Silverstein, D B Rifkin, L Ossowski.   

Abstract

Sheep pituitary glands contain a protein that stimulates plasminogen activator (PA) activity 3- to 20-fold in serum-free cultures of T47D, MTW9/PL, and SC115 breast tumor cells. This protein was found to be similar to basic fibroblast growth factor (bFGF) in size, cationic nature, and affinity for heparin. Purified human placental bFGF, a homologue of human and bovine pituitary bFGF, was effective in stimulating mammary tumor cell PA at a concentration of 1 ng/ml. Antibodies to placental bFGF blocked the PA stimulatory activity of sheep pituitary extracts. Because of these properties, the active protein in sheep pituitary glands was identified as bFGF. This represents another function of bFGF, indicating that its spectrum of target cells is wider than previously thought. Because of previously established correlations between PA production in vitro and tumor growth in vivo, we suggest that bFGF may contribute to the growth of breast carcinomas in vivo. Other types of carcinomas may also be affected by bFGF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463998      PMCID: PMC386805          DOI: 10.1073/pnas.83.20.7780

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Hypophysectomy in the treatment of metastatic mammary cancer.

Authors:  O H PEARSON; B S RAY
Journal:  Am J Surg       Date:  1960-04       Impact factor: 2.565

3.  Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins.

Authors:  S Strickland; W H Beers
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Role of pituitary hormones in the growth of human breast cancer.

Authors:  O H Pearson; A Manni; M Chambers; J Brodkey; J S Marshall
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

6.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

7.  Anterior pituitary function following hypophysectomy for breast cancer.

Authors:  A Fairney; L Morgan; A Barrett; I de Souza; G Barnes
Journal:  Clin Oncol       Date:  1976-06

8.  Activation of human breast carcinoma collagenase through plasminogen activator.

Authors:  M Paranjpe; L Engel; N Young; L A Liotta
Journal:  Life Sci       Date:  1980-04-14       Impact factor: 5.037

9.  Estrogen and the growth of breast cancer: new evidence suggests indirect action.

Authors:  S M Shafie
Journal:  Science       Date:  1980-08-08       Impact factor: 47.728

10.  Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro.

Authors:  T W Mak; G Rutledge; D J Sutherland
Journal:  Cell       Date:  1976-02       Impact factor: 41.582

View more
  2 in total

1.  bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement.

Authors:  C L Johnston; H C Cox; J J Gomm; R C Coombes
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

2.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.

Authors:  Y A Luqmani; M Graham; R C Coombes
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.